Sung Hoon Noh

17PUBLICATIONS
91CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersTe whaikaha me te Māori (Māori and disability)Cancer therapy (excl. chemotherapy and radiation therapy)Peripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 12, 2024
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.

Yoon-Koo Kang, Hyung-Don Kim, Jeong Hwan Yook

|Feb 10, 2022
Development and validation of a prognostic and predictive 32-gene signature for gastric cancer.

Jae-Ho Cheong, Sam C Wang, Sunho Park

|Sep 30, 2021
Reply to D.-C. Mo et al.

Yoon-Koo Kang, Hyung-Don Kim, Min-Hee Ryu

|Jun 16, 2021
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.

Yoon-Koo Kang, Jeong Hwan Yook, Young-Kyu Park

Pageof 3